Latest Articles

This article explores the various screening technologies used in the development of therapeutic antibodies and outlines the recent advances in this area.

We spoke with Professor Perry N. Halkitis, dean, distinguished professor and champion of LGBTQ+ rights, about the US FDA's recent reversal of its time-based deferrals and screening questions specific to gay and bisexual men for assessing blood donation eligibility.

In this article, we review the latest research in cell therapy development, including advances made in the lab that show promise for translation to the clinic, to improvements in developing, testing and manufacturing.

This article sheds light on the issue of image integrity in academic publishing and gives advice on how to reduce the risk.

In this opinion piece, Sophie Peresson explores the need for greater visibility globally on biosecurity issues and strategic leadership from multiple stakeholders to drive the conversation around standards and best practices.

Jim Brooks shares top tips to overcome the biggest validation challenges and best practices for building and implementing a digital process data strategy to lead to smarter and faster validation.

In this opinion piece, Jan Wauters discusses why collaboration in science is so important and what the Windsor Framework could mean for research in Europe.

Products coated with a small amount of drug that releases over an extended period of time aren’t suitable for traditional dissolution testing. Therefore, novel drug delivery mechanisms and devices require a new approach to this regulated technique.

In this article, discover the role HPLC plays in ensuring regulatory compliance and reliability of throughput, and how labs can automate to eliminate errors and build reliability into their processes.

In this op-ed article, Michael Kinch explains his optimism around ChatGPT which, in his words, centers around the possibility that we as a society might start to question "claims" and "truths" that we encounter daily.